Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sheridan, C. Will J&J turbocharge Crucell's vaccine portfolio?. Nat Biotechnol 28, 1223–1224 (2010). https://doi.org/10.1038/nbt1210-1223
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt1210-1223
- Springer Nature America, Inc.